My watch list
my.bionity.com  
Login  
NEWS
Current news

POWTECH 2023: A flying start with new themes and technologies

Trade Fair to expressly include the processing and handling of fluids

06-Dec-2022 POWTECH is getting off to a flying start. The Leading International Processing Trade Fair will take place in Nuremberg from 26 to 28 September 2023 – almost exactly a year after POWTECH 2022. Once again, more than 700 exhibitors from many countries will draw a large attendance of regional a ... more

Do women age differently from men?

The biological sex may be a decisive factor in the effectiveness of anti-ageing drugs

06-Dec-2022 Studies on fruit flies show how biological sex influences the effect of rapamycin, the currently most promising anti-ageing drug. Researchers from the Max Planck Institute for Biology of Ageing in Cologne and University College London report in Nature Aging that the drug only extends the li ... more

Where did Omicron come from?

Study published in Science sheds light on the origins of the SARS-CoV-2 variant

06-Dec-2022 First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charité – Universi ... more

A Quality-Conscious Protein

Discovery could lead to new therapeutic approaches for Alzheimer’s and other protein-misfolding diseases

06-Dec-2022 Researchers have identified a new function of a well-known enzyme: the signal peptidase complex is responsible for the quality control of membrane proteins. The discovery of this new function for a key enzyme in cell biology has been published in ‘Science’ and could lead to new therapeutic ... more

European Innovation Council funds Dermagnostix with 2.5 million euros

Start-up has made it its mission to push back the diagnostic boundaries

06-Dec-2022 Dermagnostix GmbH, a joint spin-off of Hahn-Schickard, Helmholtz Munich and Technical University of Munich, was one of 30 companies to qualify for a direct grant from the European Innovation Council (EIC) and will receive 2.5 million euros to bring its product portfolio to market under the ... more

Blood tests could predict survival odds for patients with metastatic cancer

By measuring the proportion of DNA in the bloodstream that comes from a tumor, liquid biopsies may be able to guide treatment discussions

06-Dec-2022 As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream. DNA can be analyzed for both the amount of DNA present and whether any potential mutations exist that may aid providers in deciding on treatments.  These tests, known as liq ... more

Caterpillars as a replacement for mammalian models in preclinical research

Research team developed an innovative and unique imaging platform

06-Dec-2022 Inflammation research is becoming more ethical and economical: caterpillars help to understand gut inflammation and enable the faster and more efficient development of new therapies. Insects, like caterpillars, suffer from the same or related diseases as humans because 75 % of genes associa ... more

New Potential Mechanism for Vision Loss Discovered

Visual cells may not simply die in some diseases, but are mechanically transported out of the retina beforehand

05-Dec-2022 Thanks to laboratory produced human mini-retinas, researchers were able to observe complex changes in the retina as they occur in macular degeneration. This enabled them to discover the so-called cell extrusion as a potential mechanism for neurodegenerative diseases. Visual cells in the hum ... more

Analysis true biological signatures without altering, stressing, or damaging cells

LevitasBio Completes Series C Financing of $35 million

05-Dec-2022 LevitasBio, Inc. announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.  The funding allows LevitasBio to accelerate its commercial success through the development of next generation hig ... more

Covestro turns to biotechnology for sustainable plastics

Progress in extracting chemicals from plants

05-Dec-2022 Covestro is expanding its competencies in industrial biotechnology. The plastics manufacturer intends to make increasing use of microorganisms and enzymes to make its products and processes even more sustainable. In particular, new recycling processes based on biotechnology are also to be d ... more

All news

Analysis true biological signatures without altering, stressing, or damaging cells

LevitasBio Completes Series C Financing of $35 million

05-Dec-2022 LevitasBio, Inc. announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.  The funding allows LevitasBio to accelerate its commercial success through the development of next generation hig ... more

Imaging the dynamic cellular zoo made easier

This work will expand the ability to simultaneously monitor many processes in cells

22-Nov-2022 Imagine the difficulty of visually keeping track of five people scattered throughout a stadium. Researchers perform far more amazing feats by simultaneously tracking many different cellular factors, but they need an expanded fluorescence toolkit to advance current capabilities. Now, in a st ... more

Highest-resolution view of subcellular, single-molecule, spatial biology

Resolve Biosciences Secures $71 Million Series B Financing

04-Nov-2022 Resolve Biosciences announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors. The company has now raised more th ... more

A new method for studying ribosome function

UIC scientists use native chemical ligation to fuse peptides to tRNAs

03-Nov-2022 Inside tiny cellular machines called ribosomes, chains of genetic material called messenger RNAs (mRNAs) are matched with the corresponding transfer RNAs (tRNAs) to create sequences of amino acids that exit the ribosome as proteins. Unfinished proteins are called nascent chainsm and they ar ... more

ZEISS microscope developers win the Deutscher Zukunftspreis 2022

The development of the ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells was honored with the Federal President's Award for Technology and Innovation

28-Oct-2022 The President of Germany, Frank-Walter Steinmeier, awarded the Deutscher Zukunftspreis 2022, The Federal President's Award for Technology and Innovation, to the team from ZEISS during a festive ceremony. The jury recognized the ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen, an ... more

EVIDENT Opens New Asia-Pacific Headquarters in Singapore

New facility supports customers and employees in the APAC region

28-Oct-2022 Evident announced the opening of its new Asia-Pacific (APAC) headquarters in Singapore, marking its ongoing commitment to expand its business and operations in the APAC region. The headquarters leads Evident’s strategy, technology and innovation in the APAC region, which includes operations ... more

Antibiotic resistance testing no longer impeded by time

Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs

26-Oct-2022 Significant time is needed to determine the drug susceptibility profile of a bacterial infection. Now, researchers from Nara Institute of Science and Technology and collaborating partners have published reports on a technology that will dramatically speed up this otherwise slow process and ... more

Gene activity in a test tube

An accurate picture of gene activity can provide the key to the development of new, targeted therapies

18-Oct-2022 When searching for the causes of illnesses and developing new treatments, it is absolutely vital to have a precise understanding of the genetic fundamentals. Würzburg researchers have devised a new technique for this purpose. Pathological processes are usually characterised by altered gene ... more

Searching the sewers for viruses

"In the future, additional tools will be integrated into the pipeline that will even enable us to predict the effects of a newly discovered mutation"

14-Oct-2022 Algorithms developed at the Max Delbrück Center are able to quickly detect new SARS-CoV-2 variants in wastewater. But that’s not all: the tool, which Altuna Akalin and his colleagues have now presented in “Science of the Total Environment”, can also find other pathogens. SARS-CoV-2 is one o ... more

Threatened Aldabra Giant Tortoise Genome Decoded

The next step will be to investigate how DNA can be used to determine the age of animals that are still alive

13-Oct-2022 They can live for more than 100 years and weigh up to 250 kilograms – Aldabra giant tortoises. Researchers at the University of Zurich have now decoded the genome of Aldabrachelys gigantea, one of only two remaining giant tortoise species worldwide. The findings will help to ensure the long ... more

All news on bioanalytics

Covestro turns to biotechnology for sustainable plastics

Progress in extracting chemicals from plants

05-Dec-2022 Covestro is expanding its competencies in industrial biotechnology. The plastics manufacturer intends to make increasing use of microorganisms and enzymes to make its products and processes even more sustainable. In particular, new recycling processes based on biotechnology are also to be d ... more

BioNTech and Ryvu Therapeutics enter partnership

Research collaboration for several small molecule immunotherapy programs

02-Dec-2022 BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics  announced that the companies have entered into a multi-target research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvu’s STIN ... more

Modified enzyme brings value to lignin monomers

Conversion of lignin into valuable chemicals

01-Dec-2022 The chemical industry faces the challenge of replacing fossil-based building blocks with green alternatives. Biomass is an interesting source of carbon-based molecules. It is also underused because some 25 percent of all plant biomass is in the form of lignin, a biopolymer that, so far, can ... more

Novel Method for Producing Genetically Modified Measles Vaccine Viruses

Recombinant Measles Viruses – Vaccine Platform and Weapon against Cancer?

01-Dec-2022 Genetically modified and attenuated measles vaccine viruses are considered a promising platform for research and development of vector vaccines and oncolytic measles viruses. The biotechnological production of these viruses is difficult, because it requires a precisely coordinated interacti ... more

Drugs from Plastic Waste

Fungi convert polyethylene waste into pharmacologically useful metabolic products

30-Nov-2022 Plastic waste is one of the most significant ecological and economic problems of our time. In the journal Angewandte Chemie, a research team has now introduced a chemical–biological method for upcycling polyethylene waste: catalytic cleavage is used to make carboxylic diacids that are subse ... more

New function of the CRISPR gene scissors discovered

Protein scissors activate defense function

29-Nov-2022 For several years now, the CRISPR/Cas9 gene scissors have been causing a sensation in science and medicine. This new tool of molecular biology has its origins in an ancient bacterial immune system. It protects bacteria from attack by so-called phages, i. e. viruses that infect bacteria. Res ... more

Peptyde Bio closes oversubscribed pre-seed round

Startup attracts capital from growing St. Louis investor community

29-Nov-2022 Peptyde Bio Inc. announced that it has closed an oversubscribed $1.2M pre-seed funding round. Peptyde Bio is the first company spun out of the Donald Danforth Plant Science Center by Danforth Technology Company (DTC), the wholly-owned subsidiary formed by the Danforth Center in February 202 ... more

SARS-CoV-2 detection in 30 minutes using gene scissors

Researchers introduce biosensor for the nucleic acid amplification-free detection of SARS-CoV-2 RNA

28-Nov-2022 CRISPR-Cas is versatile: Besides the controversial genetically modified organisms (GMOs), created through gene editing, various new scientific studies use different orthologues of the effector protein ‘Cas’ to detect nucleic acids such as DNA or RNA. In its most recent study, the research g ... more

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-n ... more

AI tailors artificial DNA for future drug development

DNA molecules made-to-order: “What otherwise takes years is now shortened to weeks or days”

25-Nov-2022 With the help of artificial intelligence, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production.  The technology can contribute to the development and production of vaccines, drugs for severe diseases, ... more

All news on biotechnology

European Innovation Council funds Dermagnostix with 2.5 million euros

Start-up has made it its mission to push back the diagnostic boundaries

06-Dec-2022 Dermagnostix GmbH, a joint spin-off of Hahn-Schickard, Helmholtz Munich and Technical University of Munich, was one of 30 companies to qualify for a direct grant from the European Innovation Council (EIC) and will receive 2.5 million euros to bring its product portfolio to market under the ... more

Blood tests could predict survival odds for patients with metastatic cancer

By measuring the proportion of DNA in the bloodstream that comes from a tumor, liquid biopsies may be able to guide treatment discussions

06-Dec-2022 As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream. DNA can be analyzed for both the amount of DNA present and whether any potential mutations exist that may aid providers in deciding on treatments.  These tests, known as liq ... more

Revolutionizing breast cancer detection through AI: iCAD and Google Health launches partnership

Google Health’s first partnership with a mammography AI vendor

01-Dec-2022 iCAD, Inc. announced a strategic development and commercialization agreement with Google Health to integrate its artificial intelligence (AI) technology into iCAD’sportfolio of breast imaging AI solutions. Marking the first commercial partnership Google Health has entered into to introduce ... more

Sinonasal cancer: AI facilitates breakthrough in diagnostics

Researchers have developed a method for classifying difficult-to-diagnose nasal cavity tumors

30-Nov-2022 Although tumors in the nasal cavity and the paranasal sinus are confined to a small space, they encompass a very broad spectrum with many tumor types. As they often do not exhibit any specific pattern or appearance, they are difficult to diagnose. This applies especially to so-called sinona ... more

Hope for first blood test to detect deadly heart inflammation

£50 blood test could improve diagnosis of myocarditis and help patients get lifesaving treatment earlier

29-Nov-2022 The first blood test to diagnose inflammation of the heart muscle (myocarditis) could be in use in as little as a year, following the discovery of a molecular signal in the blood by Queen Mary University of London researchers funded by the British Heart Foundation (BHF). The research, publi ... more

Study reveals new method of preparing imaging agents

Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics

29-Nov-2022 Dr. Benjamin Rotstein and collaborators unveil an operationally simple method to prepare carbon isotope-labeled versions of drugs and diagnostics. The development of new pharmaceuticals relies on the ability of scientists to design elegantly specific drugs for targeted clinical trials. And ... more

SARS-CoV-2 detection in 30 minutes using gene scissors

Researchers introduce biosensor for the nucleic acid amplification-free detection of SARS-CoV-2 RNA

28-Nov-2022 CRISPR-Cas is versatile: Besides the controversial genetically modified organisms (GMOs), created through gene editing, various new scientific studies use different orthologues of the effector protein ‘Cas’ to detect nucleic acids such as DNA or RNA. In its most recent study, the research g ... more

Back to culture - Corona sniffer dogs’ real-life feasibility study was successful

The overall rate of concordant results was almost 100 percent

15-Nov-2022 Research led by University of Veterinary Medicine Hannover (TiHo), in cooperation with Hannover Medical School (MHH), Robert Koch Institute, Hannover Concerts, ProEvent Hannover and AWiAS Aviation Services GmbH, examined whether trained corona detection dogs can be used in everyday life. Fo ... more

Start-up neotiv can accelerate international product launch in the fight against Alzheimer’s disease

10 million euros in Pre-Series A financing round

10-Nov-2022 Magdeburg-based digital health company neotiv, which is working on the development of digital biomarkers for early Alzheimer's screening, has successfully expanded its Pre-Series A financing round and raised 10 million euros. With the additional funds, neotiv is now able to drive nationwide ... more

A new tool for estimating people’s total exposure to potentially harmful chemicals is developed by Mount Sinai researchers

07-Nov-2022 A novel metric that estimates our “burden,” or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at Mount Sinai. In a paper published in Environmental Hea ... more

All news on diagnostics

Sartorius with continued growth in a challenging environment

Uncertainties due to the global political and economic situation currently remain high

19-Oct-2022 Sartorius closed the first nine months of 2022 in both divisions with double-digit sales revenue and earnings growth and specified its outlook for the current fiscal year. “In the first nine months, Sartorius achieved significant growth in a challenging environment. Both divisions recorded ... more

Digital lab management: Fully connected

Eppendorf partners up with eLabNext and Clustermarket

28-Sep-2022 In daily operations, lab managers usually have to monitor and manage multiple systems. If information on devices, about people and running processes is disjointed and spread across numerous data silos, managers need a lot of time to find specific data. An IoT platform can consolidate this i ... more

Hauschild SpeedMixer: Global action against US-based FlackTek Inc. and its European affiliates

Hauschild has filed suit in the US, a civil proceeding in the Netherlands, as well as a criminal proceeding in Spain, against FlackTek and its various agents

22-Sep-2022 In order to protect its worldwide known laboratory mixer “Hauschild SpeedMixer®” brand and prevent consumer injury, Hauschild GmbH & Co. KG has taken affirmative, global action to stop US-based FlackTek, Inc. and its affiliates from misappropriating Hauschild’s “SpeedMixer” brand and preven ... more

faCellitate, a BASF spin-off, raises 3.7 million euros in first financing round

First product facilitates reliable and reproducible 3D cell cultivation

12-Sep-2022 Mannheim-based life science startup faCellitate has successfully raised 3.7 million Euro in its closing of seed funding. On board are well-known investors such as SARSTEDT, HTGF, R3 Consulting, ROI Verwaltungsgesellschaft, ARVE Capital and Chemovator. The faCellitate team under the leadersh ... more

Eppendorf opens new site in Singapore

Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services

08-Aug-2022 The globally active Eppendorf Group continues its growth track in Asia in a targeted manner and has opened a new site in Singapore. The new subsidiary is located in the heart of Singapore’s modern Biopolis science center and offers attractive office workplaces for sales and service activiti ... more

Eppendorf: climate-neutral by 2028

Comprehensive climate strategy with the goal of climate neutrality by 2028

01-Aug-2022 The globally positioned Eppendorf Group, a life science specialist, is picking up speed when it comes to climate protection. The company is reducing its CO2 emissions and will be climate-neutral by 2028 – much earlier than specified by the EU. To enable this, Eppendorf has developed a compa ... more

analytica 2022 wowed the laboratory industry

analytica extended: digital extension through July 8

27-Jun-2022 An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for ... more

R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist

09-Jun-2022 R-Biopharm AG announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is there ... more

Eppendorf increases 2021 revenue to €1.1 billion

Positive trends in all market regions and product groups

11-May-2022 During fiscal year 2021, the globally positioned Eppendorf Group saw its consolidated revenue climb to €1.1 billion (prior year: €967.2 million), amounting to an increase of 13.8% (prior year: 20.3%). Operating profit also rose significantly in 2021, reaching €272 million (prior year: €217. ... more

Eppendorf builds new site in Wismar for high-tech polymers used in laboratories

Production to start by the end of the year

25-Apr-2022 The globally active Eppendorf Group is building a new plant for high-quality laboratory consumables made of functional high-tech polymers. To this end, the Hamburg-based life science company is acquiring a former production site at the location of MV Werften Fertigmodule Property GmbH in Wi ... more

All news on laboratory equipment / laboratory supplies

POWTECH 2023: A flying start with new themes and technologies

Trade Fair to expressly include the processing and handling of fluids

06-Dec-2022 POWTECH is getting off to a flying start. The Leading International Processing Trade Fair will take place in Nuremberg from 26 to 28 September 2023 – almost exactly a year after POWTECH 2022. Once again, more than 700 exhibitors from many countries will draw a large attendance of regional a ... more

BioNTech and Ryvu Therapeutics enter partnership

Research collaboration for several small molecule immunotherapy programs

02-Dec-2022 BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics  announced that the companies have entered into a multi-target research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvu’s STIN ... more

Drugs from Plastic Waste

Fungi convert polyethylene waste into pharmacologically useful metabolic products

30-Nov-2022 Plastic waste is one of the most significant ecological and economic problems of our time. In the journal Angewandte Chemie, a research team has now introduced a chemical–biological method for upcycling polyethylene waste: catalytic cleavage is used to make carboxylic diacids that are subse ... more

Sanofi moves into its new Paris global headquarters

The opening is part of a global program to modernize the Group's workspaces around the world

29-Nov-2022 Sanofi has moved into its new global headquarters in the 17th arrondissement of Paris, at 46-48 Avenue de la Grande Armée. The 9,000m² site has been designed to foster new hybrid ways of working and allows the around 500 employees to better connect, collaborate, create and celebrate. The ne ... more

After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board

Supervisory Board searches for a successor to be CEO

29-Nov-2022 Rentschler Biopharma SE announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive Officer (CEO), Dr. Frank Mathias will return to the company’s Supervisory Board at the end of the fiscal year in March 2023. He will continue t ... more

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-n ... more

CatalYm Closes EUR 50 Million Series C Financing

Start-up develops a "new anti-cancer immunotherapeutic drug with the potential to transform the immuno-oncology landscape"

24-Nov-2022 CatalYm announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesalius Biocapital III, Bayern Kapit ... more

Merck to Acquire Imago BioSciences, Inc. for $1.35 Billion

Acquisition expands Merck’s growing hematology portfolio

23-Nov-2022 Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an approximate total equity value of $1.35 ... more

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology

Merck shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity

22-Nov-2022 To achieve the goal of introducing one new product or major indication every 1.5 years on average, the company will focus its expertise and capabilities and leverage synergies within the existing pipeline to deliver transformative medicines in Oncology, Neurology and Immunology, augmented b ... more

Austrian deep-tech startup develops next-generation cell therapy manufacturing platform

Sarcura closes an oversubscribed €7M Seed Plus funding round: “If successful, they could completely change the cancer treatment landscape"

21-Nov-2022 The round was co-led by seed investors Lansdowne Investment Company Cyprus and IST Cube with participation from newly joined HCVC and tecnet equity. Besides returning seed investors Axilium Holding, Novacapital, and Nina Capital Sarcura is particularly happy to welcome newly joined European ... more

All news on pharma

Where did Omicron come from?

Study published in Science sheds light on the origins of the SARS-CoV-2 variant

06-Dec-2022 First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charité – Universi ... more

Blood tests could predict survival odds for patients with metastatic cancer

By measuring the proportion of DNA in the bloodstream that comes from a tumor, liquid biopsies may be able to guide treatment discussions

06-Dec-2022 As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream. DNA can be analyzed for both the amount of DNA present and whether any potential mutations exist that may aid providers in deciding on treatments.  These tests, known as liq ... more

Caterpillars as a replacement for mammalian models in preclinical research

Research team developed an innovative and unique imaging platform

06-Dec-2022 Inflammation research is becoming more ethical and economical: caterpillars help to understand gut inflammation and enable the faster and more efficient development of new therapies. Insects, like caterpillars, suffer from the same or related diseases as humans because 75 % of genes associa ... more

New Potential Mechanism for Vision Loss Discovered

Visual cells may not simply die in some diseases, but are mechanically transported out of the retina beforehand

05-Dec-2022 Thanks to laboratory produced human mini-retinas, researchers were able to observe complex changes in the retina as they occur in macular degeneration. This enabled them to discover the so-called cell extrusion as a potential mechanism for neurodegenerative diseases. Visual cells in the hum ... more

Commercial Dishwashers Destroy Protective Layer in Gut

Chemical residue on clean plates

02-Dec-2022 Residue from rinse agents is left behind on dishes after they are cleaned in professional-grade dishwashers. This damages the natural protective layer in the gut and can contribute to the onset of chronic diseases, as demonstrated by researchers working with organoids at the Swiss Institute ... more

Incredible discovery about mammalian brains surprises researchers

A vital enzyme is switching on/off at random, even taking hours-long breaks

02-Dec-2022 In a new breakthrough to understand more about the mammalian brain, University of Copenhagen researchers have made an incredible discovery. Namely, a vital enzyme that enables brain signals is switching on/off at random, even taking hours-long “breaks from work”. These findings may have a m ... more

Novel Method for Producing Genetically Modified Measles Vaccine Viruses

Recombinant Measles Viruses – Vaccine Platform and Weapon against Cancer?

01-Dec-2022 Genetically modified and attenuated measles vaccine viruses are considered a promising platform for research and development of vector vaccines and oncolytic measles viruses. The biotechnological production of these viruses is difficult, because it requires a precisely coordinated interacti ... more

Why are overweight people more susceptible to illness?

Size of fat cells can cause metabolic disorders

01-Dec-2022 If you gain weight, the fat cells in the body get bigger. So in the extremely obese, those fat cells are greatly enlarged. Now, researchers from the Technical University of Munich (TUM) were able to show how enlarged fat cells can cause metabolic diseases. They also developed non-invasive e ... more

Engineered proteins: A future treatment option for COVID-19

Newly engineered proteins called DARPins can decrease the presence of COVID-19 in the airways and be delivered as a nasal spray

01-Dec-2022 COVID-19 has had a lasting global health impact that continues to challenge the health care system. As the coronavirus continues to mutate, the current COVID-19 prevention strategies are plagued with supply chain disruptions, high vaccine manufacturing costs and inconvenient vaccine adminis ... more

Nanoswitches for tumor targeting

SPRIND to finance spin-off Plectonic

30-Nov-2022 The Federal Agency for Disruptive Innovation SPRIND will provide funding for the work of Plectonic Biotech in the coming years. The TUM spin-off has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of immunotherapies that target tumors ... more

All news on healthcare
News by department
  • Products

    Covestro turns to biotechnology for sustainable plastics

    Progress in extracting chemicals from plants

    05-Dec-2022 Covestro is expanding its competencies in industrial biotechnology. The plastics manufacturer intends to make increasing use of microorganisms and enzymes to make its products and processes even more sustainable. In particular, new recycling processes based on biotechnology are also to be d ... more

    Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology

    Merck shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity

    22-Nov-2022 To achieve the goal of introducing one new product or major indication every 1.5 years on average, the company will focus its expertise and capabilities and leverage synergies within the existing pipeline to deliver transformative medicines in Oncology, Neurology and Immunology, augmented b ... more

    Drug discovery and development — in space?

    The low-gravity environment could speed up the development and discovery of complex molecules used in medicines

    21-Nov-2022 Carrying out scientific experiments in space allows scientists to study and make drugs without gravity, which can lead to surprising results that improve research back on Earth. According to a cover story in Chemical & Engineering News, an independent news outlet of the American Chemical So ... more

  • Business

    POWTECH 2023: A flying start with new themes and technologies

    Trade Fair to expressly include the processing and handling of fluids

    06-Dec-2022 POWTECH is getting off to a flying start. The Leading International Processing Trade Fair will take place in Nuremberg from 26 to 28 September 2023 – almost exactly a year after POWTECH 2022. Once again, more than 700 exhibitors from many countries will draw a large attendance of regional a ... more

    Covestro turns to biotechnology for sustainable plastics

    Progress in extracting chemicals from plants

    05-Dec-2022 Covestro is expanding its competencies in industrial biotechnology. The plastics manufacturer intends to make increasing use of microorganisms and enzymes to make its products and processes even more sustainable. In particular, new recycling processes based on biotechnology are also to be d ... more

    Sanofi moves into its new Paris global headquarters

    The opening is part of a global program to modernize the Group's workspaces around the world

    29-Nov-2022 Sanofi has moved into its new global headquarters in the 17th arrondissement of Paris, at 46-48 Avenue de la Grande Armée. The 9,000m² site has been designed to foster new hybrid ways of working and allows the around 500 employees to better connect, collaborate, create and celebrate. The ne ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Do women age differently from men?

    The biological sex may be a decisive factor in the effectiveness of anti-ageing drugs

    06-Dec-2022 Studies on fruit flies show how biological sex influences the effect of rapamycin, the currently most promising anti-ageing drug. Researchers from the Max Planck Institute for Biology of Ageing in Cologne and University College London report in Nature Aging that the drug only extends the li ... more

    Where did Omicron come from?

    Study published in Science sheds light on the origins of the SARS-CoV-2 variant

    06-Dec-2022 First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal Science by researchers from Charité – Universi ... more

    A Quality-Conscious Protein

    Discovery could lead to new therapeutic approaches for Alzheimer’s and other protein-misfolding diseases

    06-Dec-2022 Researchers have identified a new function of a well-known enzyme: the signal peptidase complex is responsible for the quality control of membrane proteins. The discovery of this new function for a key enzyme in cell biology has been published in ‘Science’ and could lead to new therapeutic ... more

  • People

    After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board

    Supervisory Board searches for a successor to be CEO

    29-Nov-2022 Rentschler Biopharma SE announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive Officer (CEO), Dr. Frank Mathias will return to the company’s Supervisory Board at the end of the fiscal year in March 2023. He will continue t ... more

    Research on neural dynamics wins 2022 Eppendorf & Science Prize

    08-Nov-2022 The American scientist Ann Kennedy, Ph.D., Assistant Professor at Northwestern University, Chicago, USA has won the 2022 Eppendorf & Science Prize for Neurobiology for her work on the neural population dynamics that generate and maintain our emotions and behavioral drives. By comparing the ... more

    T-CURX GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO

    11-Oct-2022 T-CURX GmbH announces the appointment of its co-founder, Ulf Grawunder, PhD, as the new CEO of the company. T-CURX, which was co-founded by Prof. Michael Hudecek, MD, University of Würzburg, Germany, Prof. Christoph Rader, PhD, University of Florida, FL, U.S., and Ulf Grawunder, PhD, is a G ... more

  • Finances

    European Innovation Council funds Dermagnostix with 2.5 million euros

    Start-up has made it its mission to push back the diagnostic boundaries

    06-Dec-2022 Dermagnostix GmbH, a joint spin-off of Hahn-Schickard, Helmholtz Munich and Technical University of Munich, was one of 30 companies to qualify for a direct grant from the European Innovation Council (EIC) and will receive 2.5 million euros to bring its product portfolio to market under the ... more

    Analysis true biological signatures without altering, stressing, or damaging cells

    LevitasBio Completes Series C Financing of $35 million

    05-Dec-2022 LevitasBio, Inc. announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.  The funding allows LevitasBio to accelerate its commercial success through the development of next generation hig ... more

    Peptyde Bio closes oversubscribed pre-seed round

    Startup attracts capital from growing St. Louis investor community

    29-Nov-2022 Peptyde Bio Inc. announced that it has closed an oversubscribed $1.2M pre-seed funding round. Peptyde Bio is the first company spun out of the Donald Danforth Plant Science Center by Danforth Technology Company (DTC), the wholly-owned subsidiary formed by the Danforth Center in February 202 ... more

  • Cooperation

    BioNTech and Ryvu Therapeutics enter partnership

    Research collaboration for several small molecule immunotherapy programs

    02-Dec-2022 BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics  announced that the companies have entered into a multi-target research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvu’s STIN ... more

    Revolutionizing breast cancer detection through AI: iCAD and Google Health launches partnership

    Google Health’s first partnership with a mammography AI vendor

    01-Dec-2022 iCAD, Inc. announced a strategic development and commercialization agreement with Google Health to integrate its artificial intelligence (AI) technology into iCAD’sportfolio of breast imaging AI solutions. Marking the first commercial partnership Google Health has entered into to introduce ... more

    Solvay Partners with French Start-Up Ostium in Single-Use Surgical Instruments Material Recycling

    10-Nov-2022 Solvay has teamed up with French start-up Ostium in a joint project designed to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced Ixef® polyarylamide (PARA) from Solvay’s portfolio of specialty polymers. The initiative is the fir ... more

  • Technology

    Effective metal extraction with electron-stimulated microorganisms by bioleaching

    14-Jul-2022 As part of the project "BioIntElekt" (Development of an innovative small-scale, low-energy electron beam source integrated in a bioreactor system, funding reference: 601015) funded by the Fraunhofer-Gesellschaft in an internal program, metals should be mobilized with the help of bacteria. A ... more

    The 7th BioProScale Symposium took place again as in-person event in Berlin

    New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering

    12-Apr-2022 On the subject of “Scaling Up and Down of Bioprocesses: Technological Innovation and Cell Physiology Insights”, the 7th Symposium was again held on-site in Berlin from March 28 to 31, 2022. In parallel, there was also the possibility to follow the presentations online. The symposium was org ... more

    World's first toxicology testing strategy without animal testing adopted by OECD

    Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods

    30-Jun-2021 The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    MIMETAS Elected Most Innovative Company of the Netherlands

    04-Nov-2022 MIMETAS is the winner of the Dutch Innovation Award 2022. This award recognizes the company's considerable focus on innovation, contribution to the reduction of animal experimentation, leadership, organization, cooperation with partners, and market position. Henk Volberda, chairman of the j ... more

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

  • Politics

    BioM and Munich Biotech Cluster celebrate its 25th anniversary

    A quarter century of success in biotechnology

    01-Aug-2022 BioM and the Munich Biotech Cluster celebrated their 25th anniversary. Together, they can claim a great success story. With the support of the biotech cluster management organization, the life science region has become one of the most successful biotech hotspots in Europe. At the celebratio ... more

    Chemical pollution threatens biodiversity

    Scientists say more environmental pollutants should be considered in species protection

    20-Jun-2022 Environmental chemical pollution threatens biodiversity. However, the complexity of this pollution remains insufficiently recognised by decision-makers - this is what international researchers led by Gabriel Sigmund from the University of Vienna and Ksenia Groh from the Swiss Federal Instit ... more

    CureVac and GSK Enter into Pandemic Preparedness Contract with German Government

    Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency

    12-Apr-2022 CureVac N.V. and GSK announced that they have entered into a contract with the German federal government to supply mRNA vaccines within a broader tender for pandemic preparedness in Germany. Following a setup period of a maximum of two years, the contract grants the German federal governmen ... more

  • Manufacturing

    Covestro turns to biotechnology for sustainable plastics

    Progress in extracting chemicals from plants

    05-Dec-2022 Covestro is expanding its competencies in industrial biotechnology. The plastics manufacturer intends to make increasing use of microorganisms and enzymes to make its products and processes even more sustainable. In particular, new recycling processes based on biotechnology are also to be d ... more

    Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

    The new facility is planned to ensure that FUJIFILM Irvine Scientific can meet increasing market demands

    23-Nov-2022 FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific, Inc., a subsidiary of FUJIFILM Corporation, and a world leader ... more

    Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse

    The manufacturing facility is expected to be operational in H2 2024 and will create upwards of 150 new high-skill jobs

    20-Sep-2022 Evotec SE officially launched the construction of its J.POD® biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France. J.POD® Toulouse, France (EU), the second facility of its kind and the first one on European ground, will employ Just – Evotec Biologics’ flexible J.POD ... more

  • Career

    High-Tech Business KNAUER Awarded for its Family Friendliness

    03-Nov-2021 The Berlin-based company makes sure its employees are well looked after, providing support for employees and their families, especially throughout the difficult times of the pandemic. KNAUER was officially recognized as the family friendliest company in Berlin that has more than 100 employe ... more

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE